Published in Nephrol Dial Transplant on August 05, 2012
Active vitamin D treatment for reduction of residual proteinuria: a systematic review. J Am Soc Nephrol (2013) 1.17
Incidence and consequence of acute kidney injury in unselected emergency admissions to a large acute UK hospital trust. BMC Nephrol (2014) 0.99
DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease. Epigenetics (2013) 0.92
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol (2017) 0.92
Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010. BMJ Open (2014) 0.89
Peritoneal dialysis and in-centre haemodialysis: a cost-utility analysis from a UK payer perspective. Appl Health Econ Health Policy (2014) 0.88
Addressing health disparities in chronic kidney disease. Int J Environ Res Public Health (2014) 0.85
Timeliness in chronic kidney disease and albuminuria identification: a retrospective cohort study. BMC Fam Pract (2015) 0.84
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? BMC Nephrol (2015) 0.83
The need for improved identification and accurate classification of stages 3-5 Chronic Kidney Disease in primary care: retrospective cohort study. PLoS One (2014) 0.83
Awareness of chronic kidney disease in Austria: a frequently under-recognized clinical picture. Wien Klin Wochenschr (2013) 0.81
A prospective clinical trial of specialist renal nursing in the primary care setting to prevent progression of chronic kidney: a quality improvement report. BMC Fam Pract (2014) 0.81
The economic considerations of patients and caregivers in choice of dialysis modality. Hemodial Int (2016) 0.81
The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis. BMC Nephrol (2014) 0.81
Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis. Clin J Am Soc Nephrol (2015) 0.79
Are pre-existing markers of chronic kidney disease associated with short-term mortality following acute community-acquired pneumonia and sepsis? A cohort study among older people with diabetes using electronic health records. Nephrol Dial Transplant (2015) 0.79
Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial. Trials (2014) 0.78
Development of a Model of Chronic Kidney Disease in the C57BL/6 Mouse with Properties of Progressive Human CKD. Biomed Res Int (2015) 0.77
The cost of dialysis in low and middle-income countries: a systematic review. BMC Health Serv Res (2015) 0.77
Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland. Pharmacoeconomics (2015) 0.75
Budget impact of secondary hyperparathyroidism treatment in chronic kidney disease in an Ecuadorian social security hospital. BMC Health Serv Res (2016) 0.75
PAlliative Care in chronic Kidney diSease: the PACKS study--quality of life, decision making, costs and impact on carers in people managed without dialysis. BMC Nephrol (2015) 0.75
An external validation of models to predict the onset of chronic kidney disease using population-based electronic health records from Salford, UK. BMC Med (2016) 0.75
Making an IMPAKT; Improving care of Chronic Kidney Disease patients in the community through collaborative working and utilizing Information Technology. BMJ Qual Improv Rep (2017) 0.75
A retrospective case-control analysis of the outpatient expenditures for western medicine and dental treatment modalities in CKD patients in Taiwan. PLoS One (2014) 0.75
Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England. PLoS One (2017) 0.75
Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: a systematic review protocol. BMJ Open (2016) 0.75
Forecasting the Incidence and Prevalence of Patients with End-Stage Renal Disease in Malaysia up to the Year 2040. Int J Nephrol (2017) 0.75
Home hemodialysis: a comprehensive review of patient-centered and economic considerations. Clinicoecon Outcomes Res (2017) 0.75
Modulation of endogenous antioxidant defense and the progression of kidney disease in multi-heritage groups of patients with type 2 diabetes: PRospective EValuation of Early Nephropathy and its Treatment (PREVENT). J Transl Med (2016) 0.75
Developing Treatments for Chronic Kidney Disease in the 21st Century. Semin Nephrol (2016) 0.75
A review of the use of health examination data from the Health Survey for England in government policy development and implementation. Arch Public Health (2014) 0.75
Cost-effectiveness analysis of different systolic blood pressure targets for people with a history of stroke or transient ischaemic attack: Economic analysis of the PAST-BP study. Eur J Prev Cardiol (2016) 0.75
Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden. BMJ Open (2016) 0.75
Estimation of the prevalence of chronic kidney disease: The results of a model based estimation in Kerman, Iran. Med J Islam Repub Iran (2016) 0.75
What drives quality improvement in chronic kidney disease (CKD) in primary care: process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) trial. BMJ Open (2016) 0.75
Chronic kidney disease: identification and management in primary care. Pragmat Obs Res (2016) 0.75
Acute Care QUAliTy in chronic Kidney disease (ACQUATIK): a prospective cohort study exploring outcomes of patients with chronic kidney disease. BMJ Open (2015) 0.75
The social cost of chronic kidney disease in Italy. Eur J Health Econ (2016) 0.75
Psychosocial Interventions for Depressive and Anxiety Symptoms in Individuals with Chronic Kidney Disease: Systematic Review and Meta-Analysis. Front Psychol (2017) 0.75
A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events. Eur J Health Econ (2016) 0.75
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2009) 12.66
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med (2001) 6.22
Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int (2007) 3.76
Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol (2006) 2.42
Clostridium difficile colitis associated with chronic renal failure. Nephrol Dial Transplant (1998) 1.94
Making change last: applying the NHS institute for innovation and improvement sustainability model to healthcare improvement. Implement Sci (2013) 1.82
The cost of renal dialysis in a UK setting--a multicentre study. Nephrol Dial Transplant (2008) 1.81
The burden of chronic kidney disease. BMJ (2006) 1.57
Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int (1993) 1.42
Creatinine fluctuation has a greater effect than the formula to estimate glomerular filtration rate on the prevalence of chronic kidney disease. Nephron Clin Pract (2010) 1.37
Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease. J Am Soc Nephrol (2007) 1.25
Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J (2006) 1.24
Diarrhoea due to Clostridium difficile associated with antibiotic treatment in patients receiving dialysis: the role of cross infection. Br Med J (Clin Res Ed) (1986) 1.06
Dialysis for end-stage renal disease. Determining a cost-effective approach. Int J Technol Assess Health Care (2001) 0.88
The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant (2005) 2.24
A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis (2002) 1.65
Body mass index has no effect on rate of progression of chronic kidney disease in non-diabetic subjects. Nephrol Dial Transplant (2012) 1.59
Automatic categorization of diverse experimental information in the bioscience literature. BMC Bioinformatics (2012) 1.27
Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol (2010) 1.20
Factors associated with kidney disease progression and mortality in a referred CKD population. Am J Kidney Dis (2010) 1.18
The use of eGFR and ACR to predict decline in renal function in people with diabetes. Nephrol Dial Transplant (2010) 1.04
Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney disease. Am J Kidney Dis (2004) 1.00
The cost of implementing UK guidelines for the management of chronic kidney disease. Nephrol Dial Transplant (2007) 0.99
Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol (2002) 0.95
The development and piloting of the REnal specific Advanced Communication Training (REACT) programme to improve Advance Care Planning for renal patients. Palliat Med (2013) 0.93
Anaemia in patients with diabetes: unrecognised, undetected and untreated? Curr Med Res Opin (2003) 0.87
Systemic lupus erythematosus, eosinophilic vasculitis and acalculous cholecystitis. Nephrol Dial Transplant (2005) 0.85
The UK model for system redesign and chronic kidney disease services. Semin Nephrol (2009) 0.85
Epidemiology and investigation of acute abdominal presentations in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2007) 0.80
Predictive value of myocardial and coronary imaging in the long-term outcome of potential renal transplant recipients. Int J Cardiol (2009) 0.79
A decade after the KDOQI CKD/guidelines: a perspective from the United Kingdom. Am J Kidney Dis (2012) 0.78
Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study. QJM (2008) 0.78
Knowing what we do and doing what we should: quality assurance in hemodialysis. Nephron Clin Pract (2014) 0.76
Clinical decision support systems and the management of CKD by primary care physicians. Am J Kidney Dis (2011) 0.75
Variations in healthcare: Atlas helps map a course to quality improvements. Health Serv J (2012) 0.75
Impact of a high-dependency care area on the nutritional management of patients with acute uremia. J Ren Nutr (2002) 0.75
Time to decentralise renal services. Health Serv J (2009) 0.75